Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Cannabis for Acute Treatment of Migraine
NCT05427630Phase 2Suspended
- Sponsor
- University of California, San Diego
- Start
- Feb 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in migraine, sponsored by University of California, San Diego. Started Feb 2023; status: suspended.
02
Drugs
dronabinol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT05427630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05427630.